In breast, colorectal, and pancreatic cancers, MUC5B overexpression is linked to tumor proliferation, invasion, and metastasis through activation of oncogenic signaling cascades such as PI3K/AKT, Wnt/β-catenin, and ERK1/2 (33–35). Here, MUC5B is linked to neoplasm.